Nordic Alzheimer Symposium
The second Nordic Alzheimer’s Disease Symposium will be arranged Spring 2027. Sign up to news from BioArctic and Eisai to ensure that you don’t miss updates regarding the meeting.
See what our steering committee had to say about the 2025 symposium
Recordings from all lectures 2025 can be found here
The objective of the Nordic Alzheimer’s Disease symposium is to establish an annual Nordic scientific meeting place, gathering specialist healthcare professionals within the therapeutic area of Alzheimer’s disease (AD).
The symposium aims to cover scientific and clinically relevant aspects of AD. This year the focus was on the evolving treatment landscape, including new disease-modifying treatments (DMTs) and diagnostic tools – a new chapter in Alzheimer’s disease.
The meeting is initiated, organised and funded by BioArctic and Eisai. Venue, speaker fees and food are financed by the companies.
The meeting is intended for specialist healthcare professionals within the therapeutic area of Alzheimer’s disease (AD).
Current understanding of the AD patology
Prof. Heikki Tanila
University of Eastern Finland – Koupio
Clinical experience with anti-amyloid treatments in the US
Marwan Noel Sabbagh
MD, FAAN,
Department of Neurology
Barrow Neurological Institute
Contact and Questions
If you have any questions, feel free to reach out
Questions regarding the programme:
Therese Feinberg
Nordic Brand Manager, BioArctic
therese.feinberg@bioarctic.com
Nils Gamlem
Medical Advisor, BioArctic
nils.gamlem@bioarctic.com
